154 related articles for article (PubMed ID: 29278520)
21. Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations.
Poli R; Scatolini M; Grosso E; Maletta F; Gallo M; Liscia D; Nelva A; Cesario F; Forte G; Metovic J; Volante M; Arvat E; Papotti M
Endocrine; 2021 Jan; 71(1):216-224. PubMed ID: 32743766
[TBL] [Abstract][Full Text] [Related]
22. Struma ovarii and peritoneal strumosis with thyrotoxicosis.
Kim D; Cho HC; Park JW; Lee WA; Kim YM; Chung PS; Park SG; Ahn WS; Han SJ; Park CH
Thyroid; 2009 Mar; 19(3):305-8. PubMed ID: 19265502
[TBL] [Abstract][Full Text] [Related]
23. Imaging struma ovarii by means of 124I-Na PET/CT.
Lopci E; Colombo P; Rodari M; Lania A; Vitobello D; Leonardi L; Chiti A
Nucl Med Rev Cent East Eur; 2013; 16(2):95-6. PubMed ID: 24068641
[TBL] [Abstract][Full Text] [Related]
24. Lethal, malignant, metastatic struma ovarii.
Marcy PY; Thariat J; Benisvy D; Azuar P
Thyroid; 2010 Sep; 20(9):1037-40. PubMed ID: 20825300
[TBL] [Abstract][Full Text] [Related]
25. Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature.
Makani S; Kim W; Gaba AR
Gynecol Oncol; 2004 Sep; 94(3):835-9. PubMed ID: 15350384
[TBL] [Abstract][Full Text] [Related]
26. Malignant struma ovarii--a case report and review of the literature.
Hatami M; Breining D; Owers RL; Del Priore G; Goldberg GL
Gynecol Obstet Invest; 2008; 65(2):104-7. PubMed ID: 17890867
[TBL] [Abstract][Full Text] [Related]
27. Complete response of recurrent malignant struma ovarii followed by
Tang J; Hao P; Zhu W; Hu J; Wen H
J Obstet Gynaecol; 2021 Jan; 41(1):152-154. PubMed ID: 32515669
[No Abstract] [Full Text] [Related]
28. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer.
Wolff EF; Hughes M; Merino MJ; Reynolds JC; Davis JL; Cochran CS; Celi FS
Thyroid; 2010 Sep; 20(9):981-7. PubMed ID: 20718682
[TBL] [Abstract][Full Text] [Related]
29. Malignant struma ovarii: an unusual presentation.
Checrallah A; Medlej R; Saadé C; Khayat G; Halaby G
Thyroid; 2001 Sep; 11(9):889-92. PubMed ID: 11575860
[TBL] [Abstract][Full Text] [Related]
30. SPECT/CT of metastatic struma ovarii.
Koo PJ; Klingensmith WC; Bagrosky BM; Haugen BR
Clin Nucl Med; 2014 Feb; 39(2):186-7. PubMed ID: 23797234
[TBL] [Abstract][Full Text] [Related]
31. Struma Ovarii with a focus of follicular variant of papillary thyroid cancer: a case report.
Lao M; Koike J; Chauhan S; Schiano M; Plata M
W V Med J; 2008; 104(4):12-4. PubMed ID: 18646677
[TBL] [Abstract][Full Text] [Related]
32. [Cystic struma ovarii, a rare form of ovarian tumor--case report, and review of the literature].
Ostör G; Tóth I; Hrubyné Tóth Z; Bazsa S
Orv Hetil; 2007 Dec; 148(48):2285-7. PubMed ID: 18039620
[TBL] [Abstract][Full Text] [Related]
33. Malignant struma ovarii with a focus of papillary thyroid cancer: a case report.
Doganay M; Gungor T; Cavkaytar S; Sirvan L; Mollamahmutoglu L
Arch Gynecol Obstet; 2008 Apr; 277(4):371-3. PubMed ID: 17882443
[TBL] [Abstract][Full Text] [Related]
34. Papillary Thyroid Cancer in a Struma Ovarii in a 17-Year-Old Nulliparous Patient: A case Report.
Gonet A; Ślusarczyk R; Gąsior-Perczak D; Kowalik A; Kopczyński J; Kowalska A
Diagnostics (Basel); 2020 Jan; 10(1):. PubMed ID: 31952290
[No Abstract] [Full Text] [Related]
35. Unilateral malignant struma ovarii in a case of bilateral ovarian teratoma with raised CA-125 level: a rare case with treatment dilemmas.
Menon S; Deodhar K; Rekhi B; John A; Maheshwari A
Indian J Pathol Microbiol; 2011; 54(3):578-80. PubMed ID: 21934226
[TBL] [Abstract][Full Text] [Related]
36. RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration.
Elisei R; Romei C; Castagna MG; Lisi S; Vivaldi A; Faviana P; Marinò M; Ceccarelli C; Pacini F; Pinchera A
Thyroid; 2005 Dec; 15(12):1355-61. PubMed ID: 16405408
[TBL] [Abstract][Full Text] [Related]
37. Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis.
Roth LM; Karseladze AI
Int J Gynecol Pathol; 2008 Apr; 27(2):213-22. PubMed ID: 18317221
[TBL] [Abstract][Full Text] [Related]
38. [Peritoneal strumosis: an extension study with (99m)Tc-pertecnectate].
Navarro P; López L; González M; Sangrós M; Liévano P; Alvarez S; Abós D
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):97-100. PubMed ID: 21889231
[TBL] [Abstract][Full Text] [Related]
39. Metastatic struma ovarii: the burden of truth.
McDougall IR
Clin Nucl Med; 2006 Jun; 31(6):321-4. PubMed ID: 16714888
[TBL] [Abstract][Full Text] [Related]
40. Late Manifestation of Struma Peritonei and Widespread Functioning Lesions in the Setting of Struma Ovarii Simulating Highly Differentiated Follicular Carcinoma.
Ranade R; Rachh S; Basu S
J Nucl Med Technol; 2015 Sep; 43(3):231-3. PubMed ID: 25537757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
